United Kingdom· GB-APID-41431811000001104
Rezurock 200mg tablets
A belumosudil product containing belumosudil, registered in United Kingdom by Sanofi. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Belumosudil is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AA48 (belumosudil), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Belumosudil · ATC L04AA48
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Spainprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Belumosudil
- Manufacturer
- Sanofi
- Country
- United Kingdom (GB)
- ATC code
- L04AA48
- ATC class
- Belumosudil
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5000283663041
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Belumosudil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaREZUROCKSANOFI-AVENTIS CANADA INC
- United StatesRezurockKadmon Pharmaceuticals, LLC
- CzechiaREZUROCKSanofi Winthrop Industrie, Gentilly
- SpainREZUROCK 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULASanofi Winthrop Industrie
- FinlandREZUROCKSanofi Winthrop Industrie
- IrelandREZUROCK 200 mg film-coated tabletsSanofi Winthrop Industrie
- IcelandREZUROCKSanofi Winthrop Industrie
- NetherlandsREZUROCK 200 mg, filmomhulde tablettenSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rezurock
- Liechtenstein · Rezurock
- Norway · Rezurock
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/49ff8a02-71c6-45cb-88de-04693c2c1b92 GET /v1/drugs/49ff8a02-71c6-45cb-88de-04693c2c1b92?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41431811000001104",
"desc": "Rezurock 200mg tablets (Sanofi)",
"form": "Oral tablet",
"vpid": "41441911000001105",
"source": "dmd",
"vtm_id": "1163572003",
"strength": "200 mg",
"substance": "Belumosudil",
"ingredient": "Belumosudil mesilate",
"supplier_code": "9190711000001101"
}See everything about belumosudil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.